(0.28%) 5 201.94 points
(0.45%) 39 232 points
(0.18%) 16 333 points
(0.22%) $79.16
(3.48%) $2.26
(0.71%) $2 338.80
(2.63%) $28.33
(0.72%) $991.65
(-0.22%) $0.928
(-0.17%) $10.87
(-0.08%) $0.799
(0.88%) $92.55
-1.99% INR 1 583.95
Live Chart Being Loaded With Signals
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs)...
Stats | |
---|---|
Today's Volume | 883 095 |
Average Volume | 1.15M |
Market Cap | 721.89B |
EPS | INR7.86 ( 2024-05-07 ) |
Next earnings date | ( INR12.29 ) 2024-08-01 |
Last Dividend | INR4.00 ( 2023-07-14 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 37.84 |
ATR14 | INR1.947 (0.12%) |
Volume Correlation
Lupin Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lupin Limited Correlation - Currency/Commodity
Lupin Limited Financials
Annual | 2022 |
Revenue: | INR162.70B |
Gross Profit: | INR94.90B (58.33 %) |
EPS: | INR9.46 |
FY | 2022 |
Revenue: | INR162.70B |
Gross Profit: | INR94.90B (58.33 %) |
EPS: | INR9.46 |
FY | 2022 |
Revenue: | INR161.93B |
Gross Profit: | INR91.05B (56.23 %) |
EPS: | INR-33.24 |
FY | 2021 |
Revenue: | INR149.29B |
Gross Profit: | INR95.67B (64.08 %) |
EPS: | INR26.84 |
Financial Reports:
No articles found.
Lupin Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR4.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR4.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.250 | 2002-01-24 |
Last Dividend | INR4.00 | 2023-07-14 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 24 | -- |
Total Paid Out | INR80.35 | -- |
Avg. Dividend % Per Year | 0.37% | -- |
Score | 2.12 | -- |
Div. Sustainability Score | 4.31 | |
Div.Growth Potential Score | 3.91 | |
Div. Directional Score | 4.11 | -- |
Year | Amount | Yield |
---|---|---|
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR5.00 | 0.65% |
2019 | INR5.00 | 0.59% |
2020 | INR6.00 | 0.78% |
2021 | INR6.50 | 0.65% |
2022 | INR4.00 | 0.42% |
2023 | INR4.00 | 0.55% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TATAMOTORS.NS | Dividend Junior | 2023-07-28 | Sporadic | 29 | 0.14% | |
NLCINDIA.NS | Dividend Knight | 2023-09-18 | Annually | 25 | 3.45% | |
INDIGOPNTS.NS | Dividend Junior | 2023-07-28 | Annually | 3 | 0.11% | |
CLSEL.NS | Dividend Junior | 2023-09-21 | Sporadic | 4 | 0.27% | |
SATIA.NS | Dividend Junior | 2023-09-22 | Annually | 6 | 0.35% | |
MAGADSUGAR.NS | Dividend Junior | 2023-07-13 | Annually | 7 | 1.78% | |
GMDCLTD.NS | Dividend Knight | 2023-09-22 | Annually | 23 | 3.41% | |
ASTRAMICRO.NS | Dividend Junior | 2023-08-23 | Annually | 20 | 0.49% | |
TNPETRO.NS | Dividend Junior | 2023-09-18 | Sporadic | 23 | 2.02% | |
PFC.NS | Dividend King | 2023-06-16 | Quarterly | 18 | 7.12% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0938 | 1.500 | 8.12 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.139 | 1.500 | 9.57 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 7.49 | 1.000 | 8.34 | 8.34 | [3 - 30] |
operatingCashFlowPerShareTTM | 33.77 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 33.77 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.643 | 1.000 | 2.62 | 2.62 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.131 | 1.000 | 9.39 | 9.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.31 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 41.02 | 1.000 | 5.96 | 0 | [1 - 100] |
returnOnEquityTTM | 0.139 | 2.50 | 9.72 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 33.77 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.248 | 1.500 | 3.80 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 33.77 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.291 | 1.500 | -1.397 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0806 | 1.000 | -0.486 | 0 | [0.1 - 0.5] |
Total Score | 3.91 |
Lupin Limited
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited network consists of 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators